GHRH ( DrugBank: GHRH )

---

1 disease

ID	Disease name (Link within this page)	Number of trials
78	Hypopituitarism	3

78. Hypopituitarism

---

Clinical trials : 492 /  Drugs : 341 - (DrugBank : 47) / Drug target genes : 45 - Drug target pathways : 100

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT00675506 (ClinicalTrials.gov)	July 2008	7/5/2008	Effectiveness of Growth Hormone Releasing Hormone in Reducing Abdominal Fat in People Who Are Obese	Physiologic Effects of Long-Term GHRH1-44 in Abdominal Obesity	Abdominal Obesity;Growth Hormone Deficiency	Drug: Growth hormone releasing hormone (GHRH) 1-44;Drug: Placebo	Massachusetts General Hospital	National Heart, Lung, and Blood Institute (NHLBI)	Completed	18 Years	55 Years	All	60	Phase 2	United States
2	NCT00448747 (ClinicalTrials.gov)	June 2007	16/3/2007	Investigation of a New, Oral Growth Hormone Secretagogue, AEZS-130 as a Growth Hormone Stimulation Test.	A Multi-center, Study Investigating a New, Oral Growth Hormone Secretagogue (GHS)(AEZS 130, Formerly Ardana (ARD)-07) as a Growth Hormone (GH) Stimulation Test in Terms of Safety and Efficacy	Diagnosis of Adult Growth Hormone Deficiency (AGDH)	Drug: AEZS-130 (formerly ARD-07);Drug: L-ARG+GHRH	AEterna Zentaris	NULL	Completed	18 Years	N/A	All	101	Phase 3	United States
3	NCT00720902 (ClinicalTrials.gov)	February 2007	16/6/2008	Adult Growth Hormone Deficiency and Cardiovascular Risk	Assessment of Cardiovascular Risk Markers in GH Deficient Patients With Nonsecreting Pituitary Adenomas	Growth Hormone Deficiency	Procedure: Blood draws;Drug: Growth hormone releasing hormone (GHRH) and arginine;Procedure: Carotid ultrasound;Procedure: MRI;Procedure: Endothelial cell biopsy	Columbia University	NULL	Terminated	19 Years	65 Years	Both	8	N/A	United States